Jörg Scheidle has more than 20 years of experience in the life sciences industry. As Executive Chairman, he is primarily responsible for the Luye Pharma plant in Germany. Prior to joining Luye in 2008, Jörg was CFO at Immatics Biotechnologies, a clinical stage immune-oncology biotech company. He started his career at BrainLAB, where he held a variety of positions in marketing and finance and helped drive the company’s rapid growth.
Jörg Scheidle studied business at the University of Augsburg, Germany, and at the University of Dayton in the United States.
Executive Board Member, Head of Development
Dr. Björn Schurad has spent more than 15 years working in the pharmaceutical industry. He is Head of Development and an Executive Board Member at Luye Pharma AG. Prior to joining Luye in 2008, Björn Schurad was responsible for pharmaceutical development at Axxonis. He also gained extensive experience as head of quality control and served as Qualified Person for investigational medicinal products.
Björn Schurad studied pharmacy at the Free University Berlin and holds a PhD in pharmaceutical technology.
Bruno Delie has more than 20 years of experience in the global pharmaceutical business. Prior to being appointed General Manager of Luye Pharma in Switzerland, he was a board member and executive VP at Ethypharm. There, he was responsible for international development and the company’s transition to a specialty pharma model. Before joining Ethypharm, Bruno Delie acquired wide-ranging experience in corporate and business development as well as international sales and marketing. He has also worked in various licensing and sales management roles for a number of European, American, and Asian companies.
Bruno Delie is a graduate of the Pharmaceutical University of Lille and has an MBA from HEC Paris.